Patient Resources

No copy


Lorem ipsum dolor sit amet, consectetur adipiscingelit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip



FDA Approves New Flu Treatment
AAFA COMMUNITY SERVICES · 10/24/183:00 PMToday, the U.S. Food and Drug Administration ap-proved Xofluza (baloxavir marboxil) for the treatment of acute uncomplicated influenza (flu) in patients 12
years of age and older who have been symptomatic

Full Story >

AAAPC Education

Next Webinar:
January 5, 2019 – 4:00 PM Eastern
What You Need to Know to Improve Asthma Adherence Dr. Weinstein will be presenting research-
based practical strategies to help improve asthma patient adherence and outcomes.

Register Now >

© Copyright 2020 | All Rights Reserved | Online Presence By: Benson Design